Jennifer Cofer

The U.S. Food and Drug Administration (FDA) has authorized the first menthol-flavored e-cigarettes, a decision that has sparked a wave of criticism from public health leaders. Jennifer Cofer, a prominent figure at Texas's M.D. Anderson Cancer Center, is among those voicing strong objections, arguing that the authorization sends a misleading message about the safety of vaping.

The FDA's statement highlights the potential benefits for adult smokers who use e-cigarettes as a means to quit traditional cigarettes, suggesting that these benefits outweigh the risks. . .